申请人:Sugasawa Keizo
公开号:US20090286766A1
公开(公告)日:2009-11-19
Provided is an agent for treating or preventing urinary frequency, urinary urgency and urinary, incontinence which are associated with overactive bladder, a lower urinary tract disease such as interstitial cystitis and chronic prostatitis accompanied by lower urinary tract pain, and various diseases accompanied by pain. A novel azolecarboxamide derivative in which an azole ring such as thioazole or oxazole is bonded to a benzene ring, pyridine ring or pyrimidine ring through carboxamide was confirmed to have a potent trkA receptor-inhibitory activity and found to be an agent for treating or preventing lower urinary tract disease and various diseases accompanied by pain, which is excellent in efficacy and safety, and thus the present invention was accomplished.
提供了一种用于治疗或预防与过度活跃膀胱、下泌尿道疾病(如间质性膀胱炎和慢性前列腺炎伴随下泌尿道疼痛)以及伴随疼痛的各种疾病相关的尿频、尿急和尿失禁的药剂。一种新型的唑烷羧酰胺衍生物,其中唑环(如硫唑环或噁唑环)通过羧酰胺键连接到苯环、吡啶环或嘧啶环上,被证实具有强效的trkA受体抑制活性,并被发现是一种用于治疗或预防下泌尿道疾病和伴随疼痛的各种疾病的药剂,其疗效和安全性优异,因此本发明得以完成。